ENTITY
Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX US)

103
Analysis
Health Care • United States
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company develops drugs for the treatment of cystic fibrosis, autoimmune diseases, cancer, inflammatory bowel disease, and neurological disorders.
more
•24 Dec 2025 09:19•Broker

[2026 Outlook] Pharma/BiotechIdentifying Leaders Within an Outperforming Sector

In 1H25, US policy uncertainty—i.e., potential drug tariffs, the most-favored-nation (MFN) pricing proposal, and Inflation Reduction Act (IRA) drug...

Logo
358 Views
Share
bullish•Cross Asset Strategy
•04 Nov 2024 09:59•Broker

EU Mfg. PMI & Weekly Strategy

Technically, the SET Index is expected to move sideways, with the resistance at 1,468/1,477 points and the support at 1,456 points (25-day EMA)...

Logo
91 Views
Share
x